Permanent unilateral hearing loss after radiotherapy for parotid gland tumors

Head Neck. 2006 Oct;28(10):902-8. doi: 10.1002/hed.20426.

Abstract

Background: The purpose of this retrospective study was to determine the long-term effects of radiotherapy on hearing function in patients who underwent parotidectomy and postoperative radiotherapy for unilateral tumors of the parotid gland.

Methods: An extensive set of tests was used to measure hearing loss. The mean dose on middle ear, cochlea, and Eustachian tube was estimated with a CT-planning system.

Results: A hearing loss of > or = 15 dB in 3 frequencies was found in 32% of the 52 patients included in the study. Patients with an asymmetrical hearing loss received a higher mean dose on the hearing structures (p < .002). The threshold dose for clinically relevant hearing loss was found at 50 Gy on the cochlea and Eustachian tube.

Conclusions: Radiation-induced hearing loss is a common complication. A mean dose of > 50 Gy on the cochlea should be avoided.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Audiometry
  • Female
  • Hearing Loss, Unilateral / diagnosis
  • Hearing Loss, Unilateral / epidemiology
  • Hearing Loss, Unilateral / etiology*
  • Humans
  • Male
  • Middle Aged
  • Parotid Gland / surgery
  • Parotid Neoplasms / radiotherapy*
  • Parotid Neoplasms / surgery
  • Postoperative Care
  • Radiation Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Adjuvant / adverse effects
  • Retrospective Studies